PDS BIOTECHNOLOGY CORPORATION - COMMON STOCK
3.2010
01-November-24 15:59:58
15 minutes delayed
Stocks
+0.0110
+0.34%
Today's range
3.1500 - 3.3500
ISIN
N/A
Source
NASDAQ
-
PDS Biotech Announces Preclinical Data for PDS0202 Universal Influenza Vaccine
27 Jan 2022 08:00:02 By Nasdaq GlobeNewswire
-
PDS Biotechnology to Present at B. Riley Securities Virtual Oncology Conference
18 Jan 2022 08:00:01 By Nasdaq GlobeNewswire
-
12 Jan 2022 08:00:01 By Nasdaq GlobeNewswire
-
PDS Biotech Granted Patent for its Novel HPV16 Immunotherapy
10 Jan 2022 07:00:01 By Nasdaq GlobeNewswire
-
PDS Biotechnology to Present at H.C. Wainwright Bioconnect Virtual Conference
05 Jan 2022 08:00:02 By Nasdaq GlobeNewswire
-
PDS Biotech Reports An Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
23 Dec 2021 16:00:00 By Nasdaq GlobeNewswire
-
06 Dec 2021 08:30:00 By Nasdaq GlobeNewswire
-
PDS Biotech Provides Business Update and Reports Third Quarter 2021 Financial Results
10 Nov 2021 07:00:02 By Nasdaq GlobeNewswire
-
08 Nov 2021 08:30:01 By Nasdaq GlobeNewswire
-
01 Nov 2021 08:30:00 By Nasdaq GlobeNewswire
-
27 Oct 2021 08:30:00 By Nasdaq GlobeNewswire
-
PDS Biotechnology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
21 Oct 2021 16:30:00 By Nasdaq GlobeNewswire
-
21 Oct 2021 07:30:00 By Nasdaq GlobeNewswire
-
13 Oct 2021 16:30:00 By Nasdaq GlobeNewswire
-
PDS Biotechnology Welcomes Matthew Hill as Chief Financial Officer
06 Oct 2021 08:30:00 By Nasdaq GlobeNewswire
-
04 Oct 2021 08:30:00 By Nasdaq GlobeNewswire
-
PDS Biotechnology to Present at the Benzinga Healthcare Conference
27 Sep 2021 08:30:00 By Nasdaq GlobeNewswire
-
PDS Biotechnology to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference
22 Sep 2021 08:30:01 By Nasdaq GlobeNewswire
-
20 Sep 2021 08:30:00 By Nasdaq GlobeNewswire
-
PDS Biotech Reports An Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
15 Sep 2021 08:30:01 By Nasdaq GlobeNewswire